Comprehensive evaluations of Ki-67 alongside clinical variables, such as age, tumor size, laterality, or resection margin status, are scarce, with most prior studies focusing on recurrence or survival rather than metastasis at initial diagnosis [13,14]. This evidence concerns the gene MKI67 and neoplasm.